Home

Pillanat mérhető szendvics win cannabinoid itt szétkapcsolt közhely

WIN 55,212-2 - Wikipedia
WIN 55,212-2 - Wikipedia

WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris  Bioscience
WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris Bioscience

Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal  dopaminergic and cannabinoid systems in the rat brain - ScienceDirect
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain - ScienceDirect

Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the  aged rat brain | Molecular Psychiatry
Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain | Molecular Psychiatry

Effect of the synthetic cannabinoid agonist WIN 55212-2 (WIN) on... |  Download Scientific Diagram
Effect of the synthetic cannabinoid agonist WIN 55212-2 (WIN) on... | Download Scientific Diagram

Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and  IL-10 Cytokine Secretion in Human Primary Leukocytes | ACS Pharmacology &  Translational Science
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes | ACS Pharmacology & Translational Science

Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the  Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by  Tetrahydrocannabivarin
Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin

Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development |  News & Announcements | Cayman Chemical
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical

The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like  behavior and locomotion in a genetic model of absence seizures in the  elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &
The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &

Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human  osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1

The structure of synthetic cannabinoid agonists WIN 55,212-2 (WIN).... |  Download Scientific Diagram
The structure of synthetic cannabinoid agonists WIN 55,212-2 (WIN).... | Download Scientific Diagram

The cannabinoid receptor agonist WIN 55,212-2 (WIN) (( R)... | Download  Scientific Diagram
The cannabinoid receptor agonist WIN 55,212-2 (WIN) (( R)... | Download Scientific Diagram

WIN-55212-2 mesylate Supplier | CAS 131543-23-2 | Focus Biomolecules
WIN-55212-2 mesylate Supplier | CAS 131543-23-2 | Focus Biomolecules

Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development |  News & Announcements | Cayman Chemical
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical

WIN 55,212-2 mesylate | ≥99%(HPLC) | CB receptor agonist | AdooQ®
WIN 55,212-2 mesylate | ≥99%(HPLC) | CB receptor agonist | AdooQ®

Francesca Telese on LinkedIn: Our latest work on the role of cannabinoids  in inflammation: The…
Francesca Telese on LinkedIn: Our latest work on the role of cannabinoids in inflammation: The…

The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell  Lines | Anticancer Research
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research

WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris  Bioscience
WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris Bioscience

4 Dose-dependent induction of cannabinoid tetrad effects by the SCB WIN...  | Download Scientific Diagram
4 Dose-dependent induction of cannabinoid tetrad effects by the SCB WIN... | Download Scientific Diagram

Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human  osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1

Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat  Brain | Journal of Pharmacology and Experimental Therapeutics
Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain | Journal of Pharmacology and Experimental Therapeutics

WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... |  Download Scientific Diagram
WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... | Download Scientific Diagram

The effect of the cannabinoid receptor antagonist AM251 on WIN 55,... |  Download Scientific Diagram
The effect of the cannabinoid receptor antagonist AM251 on WIN 55,... | Download Scientific Diagram

What is a cannabinoid? — Why Not THC
What is a cannabinoid? — Why Not THC

Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN  55,212‐2 alters migration of early‐born glutamatergic neurons and GABAergic  interneurons in the rat cerebral cortex - Saez - 2014 - Journal
Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212‐2 alters migration of early‐born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex - Saez - 2014 - Journal

Win 55212-2 | C27H26N2O3 | CID 5311501 - PubChem
Win 55212-2 | C27H26N2O3 | CID 5311501 - PubChem